Key facts
- Oxi-Tech’s last known valuation is $4.7M (Aug 2025).
- It has raised $3.4M; the latest was Later Stage VC ($1.4M) in Aug 2025.
- Notable investors include Innovate UK, The FSE Group, UK Research and Innovation, South East Angels.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Oxi-Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxi-Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxi-Tech
Developer of a disinfection system intended to wipe out bacteria, viruses, and toxic chemicals. The company's system offers an active intelligence system that can sense and automatically manage any unwanted changes in its environment, deviation in temperature, turbidity, and pH, enabling clients to access the ozonation technology.
- Sector
- Business Products and Services (B2B)
- HQ
- Exeter, United Kingdom
- Founded
- 2017
- Employees
- 9
- Website
- oxitechsolutions.com/
- Ownership
- Privately Held (backing)
Oxi-Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxi-Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxi-Tech in its N-PORT filings yet. We sweep new filings monthly.